History of advances in genetic engineering of viruses before COVID-19 pandemic.

Q3 Medicine
Mikhail Teppone
{"title":"History of advances in genetic engineering of viruses before COVID-19 pandemic.","authors":"Mikhail Teppone","doi":"10.25259/SNI_36_2023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>On December 31, 2019, the World Health Organization's China Country Office was alerted to cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China.</p><p><strong>Methods: </strong>Due to the fact that to date, the question of the origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been resolved yet, the author analyzed the main advances in the development of genetic engineering of viruses that took place before the onset of the COVID-19 pandemic.</p><p><strong>Results: </strong>The first artificial genetically modified viruses could appear in nature in the mid-1950s. The technique of nucleic acid hybridization was developed by the end-1960s. In the late 1970s, a method called the \"reverse genetics\" emerged to synthesize ribonucleic acid and deoxyribonucleic acid molecules. In the early 1980-s, it became possible to combine the genes of different viruses and insert the genes of one virus into the genome of another virus. Since that time, the production of vector vaccines began. At present, by modern technologies one can assemble any virus based on the nucleotide sequence available in the virus database or designed by a computer as a virtual model.</p><p><strong>Conclusion: </strong>Scientists around the world are invited to answer the call of Neil Harrison and Jeffrey Sachs of Columbia University, for a thorough and independent investigation into the origin of SARS-CoV-2. Only a full understanding of the origin of the new virus can minimize the likelihood of a similar pandemic in the future.</p>","PeriodicalId":38981,"journal":{"name":"Surgical Neurology International","volume":"14 ","pages":"109"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/03/53/SNI-14-109.PMC10070288.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Neurology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/SNI_36_2023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: On December 31, 2019, the World Health Organization's China Country Office was alerted to cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China.

Methods: Due to the fact that to date, the question of the origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been resolved yet, the author analyzed the main advances in the development of genetic engineering of viruses that took place before the onset of the COVID-19 pandemic.

Results: The first artificial genetically modified viruses could appear in nature in the mid-1950s. The technique of nucleic acid hybridization was developed by the end-1960s. In the late 1970s, a method called the "reverse genetics" emerged to synthesize ribonucleic acid and deoxyribonucleic acid molecules. In the early 1980-s, it became possible to combine the genes of different viruses and insert the genes of one virus into the genome of another virus. Since that time, the production of vector vaccines began. At present, by modern technologies one can assemble any virus based on the nucleotide sequence available in the virus database or designed by a computer as a virtual model.

Conclusion: Scientists around the world are invited to answer the call of Neil Harrison and Jeffrey Sachs of Columbia University, for a thorough and independent investigation into the origin of SARS-CoV-2. Only a full understanding of the origin of the new virus can minimize the likelihood of a similar pandemic in the future.

Abstract Image

COVID-19大流行前病毒基因工程进展历史。
背景:2019年12月31日,世界卫生组织驻华办事处接到通报,中国湖北省武汉市发现不明原因肺炎病例。方法:由于SARS-CoV-2的起源问题至今尚未解决,作者分析了在COVID-19大流行发生之前病毒基因工程发展的主要进展。结果:第一个人工转基因病毒可能在20世纪50年代中期在自然界出现。核酸杂交技术是在20世纪60年代末发展起来的。20世纪70年代末,出现了一种称为“反向遗传学”的方法来合成核糖核酸和脱氧核糖核酸分子。在20世纪80年代早期,将不同病毒的基因组合起来,并将一种病毒的基因插入另一种病毒的基因组,已经成为可能。从那时起,开始生产病媒疫苗。目前,通过现代技术,人们可以根据病毒数据库中可用的核苷酸序列或计算机作为虚拟模型设计的任何病毒进行组装。结论:邀请世界各地的科学家响应哥伦比亚大学的尼尔·哈里森和杰弗里·萨克斯的号召,对SARS-CoV-2的起源进行彻底和独立的调查。只有充分了解新病毒的来源,才能最大限度地减少未来发生类似大流行的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
623
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信